Guides/Reports
AHA Comments to FDA Re: Blood Glucose Monitoring Test Systems
AHA's comment on the Food and Drug Administration’s draft guidance on blood glucose monitoring test systems for prescription point-of-care use.
View the following letter for details.
Related Resources
Advancing Health Podcast
Toolkits/Methodology
Case Studies
Case Studies